CYKILR
gene geneOn this page
Summary
CYKILR (cyclin dependent kinase inhibitor 2A regulated lncRNA, HGNC:58085) is a long non-coding RNA gene on chromosome 19q13.12.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:58085 |
| Approved symbol | CYKILR |
| Name | cyclin dependent kinase inhibitor 2A regulated lncRNA |
| Location | 19q13.12 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000267053 |
| Ensembl biotype | lncRNA |
| Entrez | 100134317 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 25 lncRNA
ENST00000586340, ENST00000586345, ENST00000586488, ENST00000590845, ENST00000600983, ENST00000655331, ENST00000657631, ENST00000660190, ENST00000660925, ENST00000670370, ENST00000702927, ENST00000784787, ENST00000784788, ENST00000784789, ENST00000784790, ENST00000784791, ENST00000784792, ENST00000784793, ENST00000784794, ENST00000784795, ENST00000784796, ENST00000784797, ENST00000784798, ENST00000784799, ENST00000784800
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000586340 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002915668 | 36310358 | 36312662 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 98.45.
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 98.45 | gold quality |
| right testis | UBERON:0004534 | 95.49 | gold quality |
| left testis | UBERON:0004533 | 95.18 | gold quality |
| testis | UBERON:0000473 | 93.92 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 88.11 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 86.30 | gold quality |
| cerebellum | UBERON:0002037 | 86.27 | gold quality |
| cerebellar cortex | UBERON:0002129 | 86.23 | gold quality |
| hypothalamus | UBERON:0001898 | 85.27 | gold quality |
| putamen | UBERON:0001874 | 84.91 | gold quality |
| amygdala | UBERON:0001876 | 84.69 | gold quality |
| temporal lobe | UBERON:0001871 | 84.55 | gold quality |
| Ammon’s horn | UBERON:0001954 | 83.82 | gold quality |
| cerebellar vermis | UBERON:0004720 | 83.82 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.63 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.61 | gold quality |
| right frontal lobe | UBERON:0002810 | 83.57 | gold quality |
| substantia nigra | UBERON:0002038 | 83.55 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.33 | gold quality |
| primary visual cortex | UBERON:0002436 | 83.03 | gold quality |
| thyroid gland | UBERON:0002046 | 83.00 | gold quality |
| brain | UBERON:0000955 | 82.66 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.63 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 82.48 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.13 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 81.78 | gold quality |
| apex of heart | UBERON:0002098 | 81.74 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 81.63 | gold quality |
| spinal cord | UBERON:0002240 | 81.55 | gold quality |
| cerebral cortex | UBERON:0000956 | 81.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.23 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.